People didn't believe Africa could be a source of innovation': how the continent holds the key to future drug research
Briefly

Prof Kelly Chibale argues that Africa's genetic diversity is crucial for effective clinical trials, as testing in Africa ensures broader drug efficacy and safety.
Chibale highlights the necessity for African involvement in research, emphasizing that historical abuses have bred mistrust in communities, necessitating local champions for change.
Read at www.theguardian.com
[
|
]